Clinical Trials Directory

Trials / Unknown

UnknownNCT05921825

Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock

Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to find the utility of red cell distribution width and lactate/albumin ratio as prognostic markers in sepsis and septic shock patients.

Detailed description

Several indicators are being used to predict the prognosis of sepsis. Commonly used prognostic indicators include Acute Physiological and chronic health evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA), Mortality in Emergency Department Score (MEDS), New York Sepsis severity score. Red cell distribution Width and lactate albumin ratio are being investigated for there prognostic value in septic patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRed cell distribution widthBlood will be drawn from the peripheral vein, arterial or a central catheter. This procedure will be done at diagnosis, 3 ,7, 14 and 21 days of sepsis
DIAGNOSTIC_TESTlactate albumin ratio measurementBlood will be drawn from the peripheral vein, arterial or a central catheter. This procedure will be done at diagnosis, 3 ,7, 14 and 21 days of sepsis

Timeline

Start date
2023-07-01
Primary completion
2024-01-30
Completion
2024-01-30
First posted
2023-06-27
Last updated
2023-06-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05921825. Inclusion in this directory is not an endorsement.